Darunavir Inhibitory Quotient Predicts the 48-Week Virological Response to Darunavir-Based Salvage Therapy in Human Immunodeficiency Virus-Infected Protease Inhibitor-Experienced Patients

The aim of this study was to evaluate the relationship between the virological response to darunavir-based salvage antiretroviral therapy and the darunavir genotypic and virtual inhibitory quotients (gIQ and vIQ, respectively). Thirty-seven HIV-infected patients failing protease inhibitor-based anti...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Moltó, José, Santos, José R., Pérez-Álvarez, Nuria, Cedeño, Samandhy, Miranda, Cristina, Khoo, Saye, Else, Laura, Llibre, Josep Maria, Valle, Marta, Clotet, Bonaventura
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology (ASM) 2008
Soggetti:
Pharmacology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2573097/
https://ncbi.nlm.nih.gov/pubmed/18725446
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00520-08
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi